Advancing Readership Needs of the Clinical Cancer Informatics Community.

JCO Clin Cancer Inform

Department of Radiation Oncology, CNS/Pediatrics Section, The University of Texas MD Anderson Cancer Center, Houston, TX.

Published: May 2024

Download full-text PDF

Source
http://dx.doi.org/10.1200/CCI.24.00024DOI Listing

Publication Analysis

Top Keywords

advancing readership
4
readership clinical
4
clinical cancer
4
cancer informatics
4
informatics community
4
advancing
1
clinical
1
cancer
1
informatics
1
community
1

Similar Publications

Study Design: Retrospective cohort.

Objective: To analyze the annual trends in the most prevalent topics, journals, and geographic regions of the top 100 spine surgery articles, as determined by altmetric attention scores (AASs). We also describe the relationship between AAS and traditional article metrics.

View Article and Find Full Text PDF

Esophageal leiomyoma is the most common benign intramural tumor of the esophagus. Despite being the most common benign tumor in its category, esophageal leiomyomas constitute only 1.2% of all esophageal tumors.

View Article and Find Full Text PDF

Antibacterial and antifouling materials for urinary catheter coatings.

Acta Biomater

December 2024

Department of Biomedical Engineering, School of Pharmaceutical University, Shenyang 110016, China. Electronic address:

Implantable medical devices have played a significant role in improving both medical care and patients' quality of life. Urinary Catheters (UCs) are commonly utilized as a substitute for bladder drainage and urine collection to prevent urinary retention in patients. However, bacterial colonization and biofilm formation on the catheter surface are prone to occur, leading to catheter-associated urinary tract infections (CAUTIs) and other complications.

View Article and Find Full Text PDF

Following the publication of this paper, it was drawn to the Editor's attention by a concerned reader that certain of the western blotting data shown in Fig. 4B on p. 4988 had already appeared in an article written by different authors at different research institutes that had already been published.

View Article and Find Full Text PDF

Current advances in nanozyme-based nanodynamic therapies for cancer.

Acta Biomater

January 2025

Department of Pharmaceutics, School of Pharmacy, Shenyang Pharmaceutical University, 103 Wenhua Road, Shenyang, Liaoning 110016, PR China. Electronic address:

Nanozymes are nano-catalysis materials with enzyme-like activities, which can repair the defects of natural enzyme such as harsh catalytic conditions, and harness their strengths to treat tumor. The emerging nanodynamic therapies improved drug selectivity and decreased drug tolerance, while causing efficient cell apoptosis through the generated reactive oxygen species (ROS). Nanodynamic therapies based on nanozymes can improve the complicated tumor microenvironment (TME) to reduce the defect rate of nanodynamic therapies, and provide more options for tumor treatment.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!